Three private practice obstetrician-gynaecologists in Singapore have been unsuccessful in their High Court challenge against the Inland Revenue Authority of Singapore (IRAS), which deemed their income extraction strategy a tax avoidance arrangement. Justice Alex Wong's ruling on Thursday reaffirmed IRAS's position that the doctors—Adrian Tan Chek Jin, Caroline Khi Yu May and Jocelyn Wong Sook Miin—had structured their medical businesses specifically to reduce their tax liability, noting in his judgment that this represents a recurring pattern among healthcare professionals caught in similar disputes with tax authorities.
The three doctors, who previously worked together at KK Women's and Children's Hospital, had devised an intricate multi-layered corporate arrangement involving multiple rounds of restructuring to separate their practices into distinct legal entities. By fragmenting their business operations, they positioned themselves to claim various tax exemptions and rebates while simultaneously paying themselves nominal monthly salaries. The strategy involved extracting the bulk of their earnings through alternative mechanisms such as tax-exempt dividends and interest-free shareholder loans, which they argued constituted legitimate business income rather than employment remuneration subject to ordinary income tax rates.
When IRAS conducted a tax audit covering the years 2013 to 2018, the authority reassessed the doctors' tax obligations by reclassifying business income that had been extracted through dividend and loan mechanisms as taxable income attributable directly to each practitioner. The revenue authority additionally adjusted corporate tax assessments for the various entities to claw back tax exemptions and rebates that the companies had previously claimed under startup and partial tax exemption schemes. After the doctors unsuccessfully sought review from the Income Tax Board of Review, they petitioned the High Court to overturn the board's decision—a move that has now been rejected.
Tan's circumstances illustrate the core weakness in the doctors' position. Drawing a monthly salary of just S$5,000 from the jointly established practice despite earning S$45,600 monthly in his previous hospital position, Tan initially justified the dramatic reduction by citing his inexperience with private entrepreneurship. However, this explanation became increasingly untenable as the practice flourished. Throughout the 2013 to 2018 period, Tan received dividends totaling S$5.14 million from one entity and S$2.35 million from another, alongside loans exceeding S$830,000 from one firm and S$2.1 million from another. Justice Wong found that Tan could provide no credible rationale for why his salary remained frozen at minimal levels while profits accumulated as tax-advantaged distributions, thereby exposing the arrangement's true purpose.
The case ultimately hinged on whether IRAS possessed lawful authority to disregard the corporate structure under provisions of the Income Tax Act designed to counteract tax avoidance. The court validated the board's determination that the intricate arrangement of multiple companies fell squarely within the scope of this anti-avoidance provision. Justice Wong explicitly rejected Tan's assertion that tax considerations played no role when the doctors initially established their private practice in 2004, observing that the deliberate choice to extract profits through tax-exempt channels rather than salary demonstrated tax motivation from inception.
The doctors' business evolution began straightforwardly when they incorporated ACJ Women's Clinic in 2004, with each partner holding equal one-third shareholdings and signing employment contracts stipulating S$5,000 monthly salaries. As their practice matured, however, they introduced subsidiary medical companies: Tan and his wife established AT OG Services in 2005, while Khi and Wong each created separate holding companies in 2007, all structured to claim tax exemptions available to newly incorporated entities. A subsequent reorganization in 2014 added a further layer—individual surgical companies for each doctor to bill inpatient services separately while the original clinic handled outpatient billing, multiplying the tax exemption opportunities across different legal entities.
This architectural complexity enabled the doctors to harness multiple tax incentive schemes. The creation of individually owned companies allowed them to qualify for both Start-Up Tax Exemption and Partial Tax Exemption benefits, essentially transforming their single integrated medical practice into what appeared on paper as multiple separate enterprises, each enjoying its own tax holidays. When they attempted to strike off some of these companies in 2016, IRAS objected and initiated comprehensive audits, ultimately concluding that tax advantage constituted a primary motivating factor in the overall arrangement.
The implications for Southeast Asian medical professionals are significant. This judgment signals that tax authorities across the region will scrutinize corporate restructurings within medical practices, particularly those involving unexplained divergences between actual earning capacity and reported salaries. The decision reinforces that artistic corporate fragmentation cannot disguise what remains functionally a single business operation generating unified income. For Malaysian doctors considering similar strategies, the ruling demonstrates that employing multiple corporate shells or dividend extraction mechanisms as primary wealth distribution channels rather than supplementary compensation tools will attract regulatory attention.
Moreover, the court's reasoning establishes that silence or implausible explanations regarding income distribution strategies will weigh heavily against practitioners defending challenged tax positions. Justice Wong emphasized that Tan's inability to articulate reasonable business justifications for maintaining S$5,000 salaries while drawing millions in dividends from increasingly profitable operations undercut his credibility. This burden-of-proof dynamic means that medical practitioners considering multi-layered corporate structures must maintain contemporaneous documentation explaining legitimate business rationales for each structural decision independent of tax considerations.
The case also highlights vulnerability in relying upon tax exemption schemes designed for startup entities when those schemes are applied within established, profitable practices through strategic corporate fragmentation. The differentiation between genuine business reasons for operating separate legal entities and artificial subdivision designed primarily to multiply tax benefits will become increasingly critical under heightened regulatory scrutiny. For Malaysian professionals, particularly those in high-income categories like specialist medicine, this judgment should prompt careful reconsideration of existing arrangements that might similarly conflate multiple tax advantages with business necessity.
Looking forward, the precedent suggests that revenue authorities throughout the region will more aggressively invoke anti-avoidance provisions when examining healthcare professionals' tax structures, particularly where patterns emerge of minimal employment income alongside substantial alternative distributions. The judgment implicitly creates a template for future challenges: regulators will identify the income actually earned, compare it against reported salary levels, and question why substantial gaps exist if not for tax reduction purposes. For Singapore's medical community and potentially practitioners across ASEAN nations, this ruling signals a clear message that sophisticated corporate structuring cannot substitute for transparent income reporting aligned with economic reality.
